AMAG Pharmaceuticals Appoints Greg Madison as Chief Commercial Officer
Description
LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced the appointment of Greg Madison as executive vice president and chief commercial officer. Mr. Madison brings a wealth of hands-on commercial experience and extensive leadership skills to AMAG. He joins AMAG from Genzyme Corporation, where he spent the past 12 years in various commercial roles in their renal division, most recently as the division’s vice president and general manager. “Through his disting a style=
Shared by: EON: Enhanced Online News
About
At EON: Enhanced Online News, we show you how to make your online press release thrive. If you want to drive traffic to your website, generate sales leads, make an announcement, or promote a new product, EON: Enhanced Online News
(More...) delivers the online visibility that you need. EON: Enhanced Online News powered by Business Wire.
Related docs
Other docs by EON
Teleflex Announces Launch of its Next Generation Vascular Positioning System®
Views: 1 | Downloads: 0
AXIS Capital Announces Publication of the Company's 2012 Loss Development Triangles
Views: 2 | Downloads: 0
AXIS Capital Holdings Limited Redeems All Outstanding 7.25% Series A Preferred Shares
Views: 1 | Downloads: 0
Wesco Aircraft Holdings, Inc. Announces Sale of Common Stock by The Carlyle Group
Views: 1 | Downloads: 0
